Key result
Carvedilol improved ejection fraction and attenuated myocardial fibrosis in rats with acute myocardial infarction via Smad3 inactivation and miR-29b upregulation.
Carvedilol attenuates post-MI myocardial fibrosis and cardiac remodeling in rats via a mechanism involving Smad3 inactivation and miR-29b upregulation.
Answers are grounded in this paper and cite their sources.
Should not change post-MI care; hypothesis-generating for carvedilol's Smad3/miR-29b effects in humans.
Carvedilol, a nonselective β-adrenoreceptor antagonist, protects against myocardial injury induced by acute myocardium infarction (AMI). The mechanisms underlying the anti-fibrotic effects of carvedilol are unknown. Recent studies have revealed the critical role of microRNAs (miRNAs) in a variety of cardiovascular diseases. This study investigated whether miR-29b is involved in the cardioprotective effect of carvedilol against AMI-induced myocardial fibrosis. Male SD rats were randomized into several groups: the sham surgery control, left anterior descending (LAD) surgery-AMI model, AMI plus low-dose carvedilol treatment (1 mg/kg per day, CAR-L), AMI plus medium-dose carvedilol treatment (5 mg/kg per day, CAR-M) and AMI plus high-dose carvedilol treatment (10 mg/kg per day, CAR-H). Cardiac remodeling and impaired heart function were observed 4 weeks after LAD surgery treatment; the observed cardiac remodeling, decreased ejection fraction, and fractional shortening were rescued in the CAR-M and CAR-H groups. The upregulated expression of Col1a1, Col3a1, and α-SMA mRNA was significantly reduced in the CAR-M and CAR-H groups. Moreover, the downregulated miR-29b was elevated in the CAR-M and CAR-H groups. The in vitro study showed that Col1a1, Col3a1, and α-SMA were downregulated and miR-29b was upregulated by carvedilol in a dose-dependent manner in rat cardiac fibroblasts. Inhibition of ROS-induced Smad3 activation by carvedilol resulted in downregulation of Col1a1, Col3a1, and α-SMA and upregulation of miR-29b derived from the miR-29b-2 precursor. Enforced expression of miR-29b significantly suppressed Col1a1, Col3a1, and α-SMA expression. Taken together, we found that smad3 inactivation and miR-29b upregulation contributed to the cardioprotective activity of carvedilol against AMI-induced myocardial fibrosis.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2013) studied Acute myocardial infarction-induced myocardial fibrosis (n=40). Carvedilol vs. Saline (untreated AMI model) was evaluated on Ejection fraction (EF) (p=<0.05). Carvedilol improved ejection fraction and attenuated myocardial fibrosis in rats with acute myocardial infarction via Smad3 inactivation and miR-29b upregulation.
Synapse has enriched 10 related papers. Consider them for comparative context: